Trial Profile
A phase I trial to investigate AMG-301 for the treatment of migraine
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 08 Sep 2015
Price :
$35
*
At a glance
- Drugs Zelminemab (Primary)
- Indications Migraine
- Focus Adverse reactions
- 08 Sep 2015 New trial record